|
|
盖尔森基兴诺卡菌致肺部感染病例1例
|
Abstract:
盖尔森基兴诺卡菌(Nocardia cyriacigeorgica)感染是一种临床患者中相对罕见的肺诺卡菌病。一般来说，诺卡菌病多发生于免疫缺陷患者中。本文报道了一名16岁免疫功能正常的男性患者，因间断胸痛半月，咳嗽咳痰8天入院，通过支气管肺泡灌洗液(bronchoalveolar lavage fluid, BALF)送检宏基因组二代测序(metagenomics Next-Generation Sequencing, mNGS)鉴定出盖尔森基兴诺卡菌感染，采用口服复方磺胺甲噁唑片联用利奈唑胺片控制感染的病例，进一步提高临床对该病的认识。
Infection with Nocardia cyriacigeorgica is a relatively rare pulmonary disease in clinical patients. Generally speaking, Nocardia is more common in immunocompromised patients. This article reports a 16-year-old male patient with normal immune function who was admitted to the hospital due to intermittent chest pain for half a month and coughing and sputum for 8 days. Through metagenomic Next-Generation Sequencing of bronchoalveolar lavage fluid, Nocardia cyriacigeorgica infection was identified. The infection was controlled using oral TMP-SMX combined with linezolid tablets, further enhancing clinical awareness of the disease.
| [1] | 张媛, 张媛媛, 李振军, 等. 诺卡氏菌研究进展[J]. 中国人兽共患病学报, 2012, 28(6): 628-634. |
| [2] | Yetmar, Z.A., Khodadadi, R.B., Chesdachai, S., et al. (2023) Mortality after Nocardiosis: Risk Factors and Evaluation of Disseminated Infection. Open Forum Infectious Diseases, 10, Ofad409. https://doi.org/10.1093/ofid/ofad409 |
| [3] | Martínez Tomás, R., Menéndez Villanueva, R., Reyes Calzada, S., et al. (2007) Pulmonary Nocardiosis: Risk Factors and Outcomes. Respirology, 12, 394-400. https://doi.org/10.1111/j.1440-1843.2007.01078.x |
| [4] | Wang, H.-L., Seo, Y.-H., Lasala, P.R., et al. (2014) Nocardiosis in 132 Patients with Cancer: Microbiological and Clinical Analyses. American Journal of Clinical Pathology, 142, 513-523. https://doi.org/10.1309/AJCPW84AFTUWMHYU |
| [5] | Majeed, A., Beatty, N., Iftikhar, A., et al. (2018) A 20-Year Experience with Nocardiosis in Solid Organ Transplant (SOT) Recipients in the Southwestern United States: A Single-Center Study. Transplant Infectious Disease, 20, E12904. https://doi.org/10.1111/tid.12904 |
| [6] | 吕天富, 陶莉莉, 朱滢, 等. 诺卡菌病28例临床分析[J]. 右江医学, 2023, 51(9): 805-814. |
| [7] | Wang, H., Zhu, Y., Cui, Q., et al. (2022) Epidemiology and Antimicrobial Resistance Profiles of the Nocardia Species in China, 2009 to 2021. Microbiology Spectrum, 10, E0156021. https://doi.org/10.1128/spectrum.01560-21 |
| [8] | Shahapur, P.R., Peerapur, B.V., Shahapur, R.P., et al. (2014) Lymphocutaneous Nocardiosis Caused by Nocardia Otitidiscaviarum: A Case Report and Review of Literature. Journal of Natural Science, Biology and Medicine, 5, 197-201. https://doi.org/10.4103/0976-9668.127328 |
| [9] | Huang, L., Chen, X., Xu, H., et al. (2019) Clinical Features, Identification, Antimicrobial Resistance Patterns of Nocardia Species in China: 2009-2017. Diagnostic Microbiology and Infectious Disease, 94, 165-172. https://doi.org/10.1016/j.diagmicrobio.2018.12.007 |
| [10] | Yassin, A.F., Rainey, F.A. and Steiner, U. (2001) Nocardia cyriacigeorgici sp. nov. The International Journal of Systematic and Evolutionary Microbiology, 51, 1419-1423. https://doi.org/10.1099/00207713-51-4-1419 |
| [11] | 刘俊枫, 周伟, 高鹏, 等. 甘肃省10例诺卡菌病患者的临床特征[J]. 中国感染控制杂志, 2022, 21(7): 661-667. |
| [12] | 高佳男, 张梦, 常静侠. 诺卡菌病34例临床分析[J]. 中国感染与化疗杂志, 2022, 22(3): 301-306. |
| [13] | Wilson, J.W. (2012) Nocardiosis: Updates and Clinical Overview. Mayo Clinic Proceedings, 87, 403-407. https://doi.org/10.1016/j.mayocp.2011.11.016 |
| [14] | Maggiorelli, C., Di Pierro, I., Manta, C., et al. (2015) Nocardia and Lungs in COPD: Beyond Immuno-Deficiencies. COPD, 12, 315-319. https://doi.org/10.3109/15412555.2014.933951 |
| [15] | 周丽娟, 邱玉英, 曹孟淑, 等. 基于宏基因组二代测序诊断的肺诺卡菌病临床分析[J]. 东南国防医药, 2023, 25(2): 122-128. |
| [16] | 李娟, 刘前军, 王开金. 以双肺多发空洞为主要表现的圣堂诺卡菌感染1例[J]. 中国感染与化疗杂志, 2020, 20(1): 92-94. |
| [17] | Steinbrink, J., Leavens, J., Kauffman, C.A., et al. (2018) Manifestations and Outcomes of Nocardia Infections: Comparison of Immunocompromised and Nonimmunocompromised Adult Patients. Medicine (Baltimore), 97, E12436. https://doi.org/10.1097/MD.0000000000012436 |
| [18] | Traxler, R.M., Bell, M.E., Lasker, B., et al. (2022) Updated Review on Nocardia Species: 2006-2021. Clinical Microbiology Reviews, 35, e0002721. https://doi.org/10.1128/cmr.00027-21 |
| [19] | 夏玉朝, 杨萱, 班立芳, 等. 10例奴卡菌感染病例的临床特点及治疗[J]. 中国感染控制杂志, 2017, 16(5): 453-457. |
| [20] | Han, D., Li, Z., Li, R., et al. (2019) MNGS in Clinical Microbiology Laboratories: On the Road to Maturity. Critical Reviews in Microbiology, 45, 668-685. https://doi.org/10.1080/1040841X.2019.1681933 |
| [21] | Margalit, I., Lebeaux, D., Tishler, O., et al. (2021) How Do I Manage Nocardiosis? Clinical Microbiology and Infection, 27, 550-558. https://doi.org/10.1016/j.cmi.2020.12.019 |
| [22] | Hamdi, A.M., Fida, M., Deml, S.M., et al. (2020) Retrospective Analysis of Antimicrobial Susceptibility Profiles of Nocardia Species from a Tertiary Hospital and Reference Laboratory, 2011 to 2017. Antimicrobial Agents and Chemotherapy, 64, e01868-19. https://doi.org/10.1128/AAC.01868-19 |
| [23] | Hershko, Y., Levytskyi, K., Rannon, E., et al. (2023) Phenotypic and Genotypic Analysis of Antimicrobial Resistance in Nocardia Species. Journal of Antimicrobial Chemotherapy, 78, 2306-2314. https://doi.org/10.1093/jac/dkad236 |
| [24] | Wallace, R.J., Septimus, E.J., Williams, T.W., et al. (1982) Use of Trimethoprim-Sulfamethoxazole for Treatment of Infections Due to Nocardia. Reviews of Infectious Diseases, 4, 315-325. https://doi.org/10.1093/clinids/4.2.315 |
| [25] | Davidson, N., Grigg, M.J., Mcguinness, S.L., et al. (2020) Safety and Outcomes of Linezolid Use for Nocardiosis. Open Forum Infectious Diseases, 7, Ofaa090. https://doi.org/10.1093/ofid/ofaa090 |
